Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?
Titel:
Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?
Auteur:
Sanmamed, Noelia Gómez-Rivas, Juan Buchser, David Montijano, Miguel Gómez-Aparicio, María Antonia Duque-Santana, Victor Torres, Lisselott Zilli, Thomas Ost, Piet Maldonado, Antonio López-Campos, Fernando Couñago, Felipe